Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 4, 2008 - Issue 6
Submit an article Journal homepage
52
Views
8
CrossRef citations to date
0
Altmetric
Review

Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab

Daanish Hoda1 Division of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
,
George R Simon1 Division of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
&
Christopher R Garrett1 Division of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA;2 Current affiliation: Department of Gastrointestinal Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
Pages 1221-1227 | Published online: 05 Dec 2008

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ibrahim H Sahin & Christopher R Garrett. (2014) Predicting cetuximab efficacy in patients with advanced colorectal cancer. Current Biomarker Findings 4, pages 61-68.
Read now

Articles from other publishers (7)

Yi Cheng Chu, Tung-Yao Tsai, Vijesh Kumar Yadav, Li Deng, Chun-Chih Huang, Yew-Min Tzeng, Chi-Tai Yeh & Ming-Yao Chen. (2021) 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis. International Journal of Molecular Sciences 22:14, pages 7508.
Crossref
Samira Bahrami, Bahram Kazemi, Hakimeh Zali, Peter C. Black, Abbas Basiri, Mojgan Bandehpour, Mehdi Hedayati & Amirhossein Sahebkar. (2020) Discovering Therapeutic Protein Targets for Bladder Cancer Using Proteomic Data Analysis. Current Molecular Pharmacology 13:2, pages 150-172.
Crossref
Marta Herreros-Villanueva, Chih-Chieh Chen, Shyng-Shiou F. Yuan, Ta-Chih Liu & Tze-Kiong Er. (2014) KRAS mutations: Analytical considerations. Clinica Chimica Acta 431, pages 211-220.
Crossref
Christopher M. Jones, Jennifer S. Pascoe & Jamie J. Coleman. (2012) Adverse reactions to monoclonal agents used in the treatment of cancer. Adverse Drug Reaction Bulletin 277:1, pages 1067-1070.
Crossref
J.J. Gemmete & S.K. Mukherji. (2011) Panitumumab (Vectibix): Fig 1.. American Journal of Neuroradiology 32:6, pages 1002-1003.
Crossref
Olivier Bouché, Giordano Domenico Beretta, Pilar García Alfonso & Michael Geissler. (2010) The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer. Cancer Treatment Reviews 36, pages S1-S10.
Crossref
Béla Pikó. (2009) Panitumumab alkalmazása az áttétes vastag- és végbélrákos betegek kezelésébenPanitumumab-treatment of metastatic colorectal cancer. Magyar Onkológia 53:2, pages 135-142.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.